Waltham, MA, United States of America

Marc Santolini

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
4 patents (USPTO):

Title: The Innovations of Marc Santolini

Introduction

Marc Santolini is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune disorders. With a total of 4 patents to his name, Santolini's work focuses on utilizing machine learning classifiers to enhance treatment efficacy for patients suffering from rheumatoid arthritis.

Latest Patents

Santolini's latest patents include innovative methods for treating subjects with rheumatoid arthritis using anti-TNF therapy. One of his patents presents systems and methods for developing classifiers that predict patient responses to specific treatments. This method involves administering alternatives to anti-TNF therapy to patients identified as non-responsive through a trained classifier. The classifier distinguishes between responsive and non-responsive subjects based on prior treatment outcomes.

Career Highlights

Marc Santolini is currently associated with Scipher Medicine Corporation, where he continues to advance his research and innovations. His work is pivotal in bridging the gap between machine learning and personalized medicine, providing new avenues for treatment in complex autoimmune conditions.

Collaborations

Santolini collaborates with esteemed colleagues such as Theodore R Mellors and Asher Ameli. Their combined expertise fosters a dynamic research environment that enhances the development of innovative treatment methodologies.

Conclusion

Marc Santolini's contributions to the field of medicine through his patents and collaborative efforts highlight the importance of innovation in improving patient care. His work exemplifies the intersection of technology and healthcare, paving the way for future advancements in treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…